HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 65.00
-0.60 (-0.91%)
Aug 12, 2025, 1:58 PM CST
Paramount Global Market Cap
HeXun Biosciences has a market cap or net worth of 2.98 billion as of August 11, 2025. Its market cap has decreased by -13.15% in one year.
Market Cap
2.98B
Enterprise Value
2.64B
Revenue
286.42M
Ranking
n/a
PE Ratio
20.22
Stock Price
$65.00
Market Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.98B, a decrease of -28.43%. That is a compound annual growth rate of -15.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.98B | -4.15% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 57.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.81B |
| Center Laboratories | 27.03B |
| Pegavision | 24.80B |